Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis (2025)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2025.120447
- Subjects: PREVENÇÃO DE DOENÇAS; DOENÇAS CARDIOVASCULARES; CUSTOS DOS CUIDADOS DE SAÚDE
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 409, article ID 120447, p, 2025
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MORTON, Jedidiah I. et al. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis. Atherosclerosis, v. 409, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90787. Acesso em: 11 abr. 2026. -
APA
Morton, J. I., Kronenberg, F., Daccord, M., Bedlington, N., Geanta, M., Silberzahn, T., et al. (2025). Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis. Atherosclerosis, 409. doi:10.1016/j.atherosclerosis.2025.120447 -
NLM
Morton JI, Kronenberg F, Daccord M, Bedlington N, Geanta M, Silberzahn T, Chen Z, Eisele J-L, Eliasen B, Santos Filho RD dos. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis [Internet]. Atherosclerosis. 2025 ; 409[citado 2026 abr. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90787 -
Vancouver
Morton JI, Kronenberg F, Daccord M, Bedlington N, Geanta M, Silberzahn T, Chen Z, Eisele J-L, Eliasen B, Santos Filho RD dos. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis [Internet]. Atherosclerosis. 2025 ; 409[citado 2026 abr. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90787 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
